SEC 13F Intelligence

Ghost Tree Capital, LLC / BBIO

Ghost Tree Capital, LLC’s Bridgebio Pharma Inc Position

Does Ghost Tree Capital, LLC own Bridgebio Pharma Inc (BBIO)? Yes — 175.0K shares worth $4M (+1.35% of its 13F portfolio) as of Q3 2024, up from 140.0K shares the prior filed quarter.

Position Value
$4M
Q3 2024
Shares
175.0K
% of Portfolio
+1.35%
Quarters Held
7
currently held

Position History BBIO

Reported value by quarter
Q1 ’23: $415,000Q1 ’23Q2 ’23: $722,400Q2 ’23Q3 ’23: $2MQ3 ’23Q4 ’23: $5MQ4 ’23Q1 ’24: $5MQ1 ’24Q2 ’24: $4MQ2 ’24Q3 ’24: $4MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024175.0K$4M+1.35%
Q2 2024140.0K$4M+1.11%
Q1 2024175.0K$5M+1.50%
Q4 2023125.0K$5M+1.65%
Q3 202375.0K$2M+0.65%
Q2 202342.0K$722,400+0.24%
Q1 202325.0K$415,000+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of BBIO.